Scaffolding proteins of the neuronal post-synaptic density (PSD) are principal organizers of glutamatergic neurotransmission that bring together glutamate receptors and signaling molecules at discrete synaptic locations. Genetic alterations of individual PSD scaffolds therefore disrupt the function of entire multiprotein modules rather than a single glutamatergic mechanism, and thus induce a range of molecular and structural abnormalities in affected neurons. Despite such broad molecular consequences, knockout, knockdown, or knockin of glutamate receptor scaffolds typically affect a subset of specific behaviors and thereby mold and specialize the actions of the ubiquitous glutamatergic neurotransmitter system. Approaches designed to control the function of neuronal scaffolds may therefore have high potential to restore behavioral morbidities and comorbidities in patients with psychiatric disorders. Here we summarize a series of experiments with genetically modified mice revealing the roles of main N-methyl-Daspartate (NMDA) and group I metabotropic glutamate (mGluR1/5) receptor scaffolds in behavior, discuss the clinical implications of the findings, and propose future research directions.
Introduction
About 60-70% of neurotransmission in the brain is excitatory and mediated by the amino acid glutamate. By acting through three classes of ionotropic receptors and three classes of metabotropic receptors, each containing a multitude of subunits, glutamate affects almost every aspect of brain function, including complex behavior (Choudhury, Lahiri, & Rajamma, 2012; Lipsky & Goldman, 2003) . Yet, there is specificity to glutamate actions conferred by receptor subunits, their neuroanatomical localization (Mori & Mishina, 2003) , or activation within a particular monoaminergic system (Zweifel, Argilli, Bonci, & Palmiter, 2008) . Another level of distinction is achieved by a class of molecules known as docking or scaffolding proteins. Scaffolds of excitatory neurons are localized at the PSD, a specialized matrix of postsynaptic terminals, where they play a critical role in glutamatergic neurotransmission. Scaffolding proteins contain domains that constrain their interactions to subsets of molecules and thereby form postsynaptic complexes with specific functions. Typically, such complexes include surface and intracellular receptors, adhesion molecules, kinases, phosphatases, small GTPases, and the actin cytoskeleton (Sheng & Hoogenraad, 2007) . By bringing together and organizing these different components of glutamate receptor complexes throughout the development and adulthood, scaffold molecules regulate glutamate receptor trafficking and signaling, dendritic structure and function, synaptic plasticity, and behavior (Fagni, Ango, Perroy, & Bockaert, 2004; van Zundert, Yoshii, & Constantine-Paton, 2004) .
The roles of PSD scaffolds in molecular and cellular processes within the central nervous system (CNS) have been recently reviewed in depth (Emes & Grant, 2012; Verpelli, Schmeisser, Sala, & Boeckers, 2012; Zheng, Seabold, Horak, & Petralia, 2011) . Here we present an overview of their behavior roles revealed by studies with genetically modified mice, focusing on the NMDAR and mGluR1/5 scaffolds of the MAGUK (membrane-associated guanylyl kinase), Shank (SH3 domain and ankyrin repeat-containing protein) and Homer families (Fig. 1) . Together with human studies, these mouse genetic experiments highlight the abnormal function of scaffolding proteins as a candidate mechanisms of post-traumatic stress disorder (PTSD), major depression, schizophrenia, and autism (Grant, 2012; Iasevoli, Tomasetti, & de Bartolomeis, 2013) .
PSD-MAGUK family
PSD-MAGUKs, including PSD-95, SAP102, PSD-93, and SAP97, comprise five protein-protein interacting domains, namely three
